Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M120,063Revenue $M20,063Net Margin (%)27.7Z-Score2.8
Enterprise Value $M123,048EPS $6.7Operating Margin %33.3F-Score5
P/E(ttm))21.5Cash Flow Per Share $6.7Pre-tax Margin (%)30.4Higher ROA y-yN
Price/Book4.610-y EBITDA Growth Rate %11.2Quick Ratio5.1Cash flow > EarningsY
Price/Sales6.05-y EBITDA Growth Rate %10.4Current Ratio5.5Lower Leverage y-yY
Price/Cash Flow13.3y-y EBITDA Growth Rate %21.8ROA % (ttm)8.3Higher Current Ratio y-yY
Dividend Yield %1.6Insider Buy (3m)1ROE % (ttm)22.9Less Shares Outstanding y-yN
Payout Ratio %35.0Shares Outstanding M760ROI % (ttm)8.2Gross Margin Increase y-yN

Gurus Latest Trades with AMGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMGNMario Gabelli 2015-03-31 Add$150.01 - $170.1
($157.49)
$ 160.362%Add 1.23%39,985
AMGNKen Fisher 2015-03-31 Add$150.01 - $170.1
($157.49)
$ 160.362%Add 1.41%156,623
AMGNVanguard Health Care Fund 2014-12-31 Reduce-0.51%$130.45 - $171.64
($155.84)
$ 160.363%Reduce -20.54%5,580,485
AMGNMario Gabelli 2014-12-31 Reduce-0.02%$130.45 - $171.64
($155.84)
$ 160.363%Reduce -34.11%39,500
AMGNJoel Greenblatt 2014-12-31 Add0.01%$130.45 - $171.64
($156.25)
$ 160.363%Add 285.93%10,393
AMGNVanguard Health Care Fund 2014-09-30 Reduce-0.32%$115.39 - $144.01
($130.57)
$ 160.3619%Reduce -12.75%7,022,755
AMGNJean-Marie Eveillard 2014-09-30 Buy 0.25%$115.39 - $144.01
($130.57)
$ 160.3619%New holding714,178
AMGNKen Fisher 2014-09-30 Add0.02%$115.39 - $144.01
($130.57)
$ 160.3619%Add 83.59%156,629
AMGNJoel Greenblatt 2014-09-30 Reduce-0.01%$115.39 - $144.01
($130.57)
$ 160.3619%Reduce -72.90%2,693
AMGNRuane Cunniff 2014-09-30 Buy $115.39 - $144.01
($130.57)
$ 160.3619%New holding1,617
AMGNVanguard Health Care Fund 2014-06-30 Reduce-0.06%$110.29 - $126.07
($115.88)
$ 160.3628%Reduce -2.00%8,049,455
AMGNMario Gabelli 2014-06-30 Add0.02%$110.29 - $126.07
($115.72)
$ 160.3628%Add 85.28%60,335
AMGNJoel Greenblatt 2014-06-30 Buy 0.02%$110.29 - $126.07
($115.72)
$ 160.3628%New holding9,938
AMGNKen Fisher 2014-06-30 Add0.01%$110.29 - $126.07
($115.72)
$ 160.3628%Add 71.02%85,316
AMGNDodge & Cox 2014-06-30 Reduce$110.29 - $126.07
($115.88)
$ 160.3628%Reduce -18.82%85,857
AMGNVanguard Health Care Fund 2014-03-31 Reduce-0.2%$113.48 - $127.47
($120.95)
$ 160.3625%Reduce -6.40%8,213,855
AMGNJoel Greenblatt 2014-03-31 Sold Out -0.06%$113.48 - $127.47
($121.04)
$ 160.3625%Sold Out0
AMGNMario Gabelli 2014-03-31 Add0.01%$113.48 - $127.47
($121.04)
$ 160.3625%Add 37.87%32,565
AMGNKen Fisher 2014-03-31 Add0.01%$113.48 - $127.47
($120.95)
$ 160.3625%Add 754.67%49,887
AMGNDodge & Cox 2014-03-31 Reduce$113.48 - $127.47
($121.04)
$ 160.3625%Reduce -22.59%105,757
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AMGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Harper Sean EEVP, Research & Development 2015-04-22Sell28,000$171.58-1.4view
Tross Stuart ASVP, Human Resources 2015-03-03Sell4,415$157.747.25view
BALTIMORE DAVIDDirector 2015-03-02Sell3,647$158.766.56view
Bradway Robert AChairman, CEO and President 2015-02-11Sell22,000$152.6910.79view
HERRINGER FRANK CDirector 2015-02-05Buy3,000$152.2911.08view
de Carbonnel FrancoisDirector 2014-12-03Sell3,000$168.010.69view
Harper Sean EEVP, Research & Development 2014-08-05Sell14,000$127.2932.9view
Patton Cynthia MSVP & CCO 2014-08-05Sell2,644$127.9732.2view
Dittrich Thomas J.W.VP, Finance & CAO 2014-05-21Sell4,130$112.8349.93view
Bradway Robert AChairman, CEO and President 2014-05-12Buy894$111.7751.36view

Press Releases about AMGN :

    Quarterly/Annual Reports about AMGN:

    News about AMGN:

    Articles On GuruFocus.com
    Amgen Reports An Upbeat Q1 Earnings Apr 23 2015 
    Amgen Inc.’s First Quarter Earnings Preview – What Could Be In Store? Apr 20 2015 
    Amgen’s First Drug For Cardiovascular Disease Gets The Green Light Apr 17 2015 
    Vanguard Health Care Fund Comments on Amgen Inc Mar 27 2015 
    Vanguard Health Care Fund 2014 Annual Report Mar 27 2015 
    Biogen And Idec To Part Ways After Inventing Alzheimer's Drug Mar 27 2015 
    Cracking The Best Healthcare Dividend Stock Secrets Mar 02 2015 
    Third Point LLC: Fourth Quarter Letter To Investors Feb 13 2015 
    Daniel Loeb Comments on Amgen Inc Feb 10 2015 
    Dan Loeb Fourth Quarter Investor Letter Feb 10 2015 


    More From Other Websites
    Final Glance: Biotechnology companies Apr 23 2015
    Final Glance: Biotechnology companies Apr 23 2015
    Kemper Freeman still unsure Expedia is moving to Seattle Apr 23 2015
    AbbVie Profit Rises on Broad Sales Growth Apr 23 2015
    Midday Glance: Biotechnology companies Apr 23 2015
    Midday Glance: Biotechnology companies Apr 23 2015
    Early Glance: Biotechnology companies Apr 23 2015
    Early Glance: Biotechnology companies Apr 23 2015
    AbbVie raises outlook as Humira again delivers earnings beat Apr 23 2015
    AbbVie raises outlook as Humira again delivers earnings beat Apr 23 2015
    3 Top Stocks to Buy That Delivered Great Earnings Apr 23 2015
    AbbVie raises guidance after 1Q sales beat Apr 23 2015
    AbbVie raises guidance after 1Q sales beat Apr 23 2015
    The Zacks Analyst Blog Highlights: Amgen, Medicines, Athersys and Alnylam - Press Releases Apr 23 2015
    Top Analyst Upgrades and Downgrades: Barrick, Facebook, Halcon, Qualcomm, Synchrony, Texas... Apr 23 2015
    Novartis starts to reap rewards of revamp Apr 23 2015
    Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys -... Apr 22 2015
    Stocks Mildly Higher; China Nods To Visa, MasterCard Apr 22 2015
    Technological Innovation Increases Amgen’s Earnings and Stock Price Apr 22 2015
    Amgen: But What About the Biosimilars? Apr 22 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK